Apple is a second-half story, and we see limited near-term catalysts for Celgene, so we're taking gains off the table.
We're taking profits in CMI, JCI and CELG and adding to FCX.
Meanwhile, defensive stocks and bonds caught a bid.
Here are the latest numbers in our portfolio.
Ahead of the earnings report, we'll look for an alternative to a long stock position.
Financials approach earnings season. Beware of investment banks.
This is not a thesis changer for us.
If shares are pressured further, we will add to our position.
We start a position in Freeport-McMoRan and trim some of our Yum! position.
We were active in adding to our existing positions and taking some profits.